Concepedia

Author

Shen Lin

Fujian Medical UniversityORCID

Also Known As

L J Shen, Lihao Shen, Lin Shen, Lina Shen, S. Lin, S.J. Lin, Shanglu Lin, Shen Lin, Siya Lin, Stingone, J.A.

49

Publications

438

Citations

10

H-Index

15

Concepts

All Affiliations

Fujian Medical UniversityFirst Affiliated Hospital of Fujian Medical UniversityTexas A&M University
SL

About

Shen Lin is an author at Fujian Medical University specializing in oncology, medicine, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

120

2

Cancer Therapeutics

2

2

79

3

Obstetrics

1

1

18

4

Pharmacology

1

1

23

5

Drug Development

1

1

23

Shen Lin

×

8

Publications

221

Citations

8

H-Index

YearCitations

Cost-effectiveness of atezolizumab plus chemotherapy for advanced non-small-cell lung cancer

Shen Lin, Shaohong Luo, Lixian Zhong,

International Journal of Clinical Pharmacy

2020

67

First-Line Treatment With Atezolizumab Plus Nab-Paclitaxel for Advanced Triple-Negative Breast Cancer

Xiuhua Weng, Xiaoting Huang, Hongchao Li,

American Journal of Clinical Oncology

2020

42

Cost‐Utility Analysis of Pembrolizumab Versus Chemotherapy as First-Line Treatment for Metastatic Non-Small Cell Lung Cancer With Different PD-L1 Expression Levels

Xiuhua Weng, Shaohong Luo, Shen Lin,

Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics

2019

32

Challenges in anticancer drug R&D in China

Shen Zhao, Cheng Lv, Jifang Gong,

The Lancet Oncology

2019

23

First-line Treatment with Ribociclib plus Endocrine Therapy for Premenopausal Women with Hormone-receptor-positive Advanced Breast Cancer: A Cost-effectiveness Analysis

Xiaoting Huang, Shen Lin, Xin Rao,

Clinical Breast Cancer

2021

18

Cost-effectiveness analysis of genotype screening and therapeutic drug monitoring in patients with inflammatory bowel disease treated with azathioprine therapy: a Chinese healthcare perspective using real-world data

Dayong Zeng, Xiaoting Huang, Shen Lin,

Annals of Translational Medicine

2021

17

Evaluation of Tucatinib in HER2-Positive Breast Cancer Patients With Brain Metastases: A United States-Based Cost-Effectiveness Analysis

Liangliang Dong, Shen Lin, Lixian Zhong,

Clinical Breast Cancer

2021

12

Green Technology Innovation under China’s New Development Concept: The Effects of Policy-Push and Demand-Pull on Renewable Energy Innovation

Yanghua Huang, Jingbo Cui, Shen Lin

Social Sciences in China

2023

10

Page 1